Medicare drug price negotiations: A game-changer for seniors’ healthcare
By
Luka Yancopoulos
Nov 02, 2023
The relatively recent passage of the Inflation Reduction Act, which among other provisions, allows Medicare to negotiate prescription drug prices, marks a monumental shift in senior healthcare in America.
Immunocompromised may need fourth COVID-19 shot: CDC
Oct 27, 2021
Small studies have shown that fully vaccinated immunocompromised people account for ~44% of breakthrough cases leading to hospitalization.
Vaccination ups infection-acquired immunity against SARS-CoV-2
Mar 01, 2022
Two doses of the BNT162b2 (Pfizer-BioNTech) vaccine were linked to high short-term protection against infection, which wanes after six months.
Risk for breakthrough SARS-CoV-2 infection lower with mRNA-1273
Feb 02, 2022
The risk for breakthrough infection and of 60-day hospitalization was significantly lower for mRNA-1273 (Moderna) versus BNT162b2 (Pfizer-BioNTech) vaccination.
Long-term care workers must be vaccinated by Jan. 4 under OSHA, CMS rules
By
Kathleen Steele Gaivin
Nov 05, 2021
Jan. 4 is the COVID-19 vaccination deadline for employees in companies that have 100 or more workers, as well as for employees of long-term care facilities that participate in Medicare and Medicaid, according...
Biden outlines measures to fight omicron, pleads with Americans to get vaccinated
Dec 21, 2021
Included in the battle plan announced Tuesday are measures to distribute 500 million free rapid COVID-19 tests to the public.
BNT162b2 protects against COVID-19 hospitalization for up to six months
Oct 06, 2021
The effectiveness of full vaccination against SARS-CoV-2 infections caused by the delta variant or other variants wanes more quickly. The BNT162b2 vaccine also is known as the Pfizer-BioNTech or Comirnaty...
FDA panel supports rollout of tweaked booster shots from Moderna, Pfizer this fall
Jun 29, 2022
The advisory panel approval speeds the process by which FDA regulators will push for updated booster formulations.
Education on approval process may increase acceptance of new RSV vaccines
Aug 14, 2023
Just 13% of respondents knew about the existence of an approved vaccine against RSV for older adults. Those educated on vaccine approval process or about potential severity of RSV may be more accepting.
Second COVID-19 vaccine shot may keep healthcare workers home the next day, expert says
By
Joe Jancsurak
Feb 16, 2021
Home care agencies may want to consider giving their workers a day off following the second dose of the COVID-19 vaccine. At least, that’s what one medical expert is suggesting.